FDA To Close Regional Offices, Consolidate Districts Under ORA Reorg
This article was originally published in The Tan Sheet
Executive Summary
FDA's decision to reorganize the Office of Regulatory Affairs will cause a "slow motion effect" for industry's interaction with FDA, according to a dietary supplement trade group executive